Madhu S. Mondal Dabt

Madhu S. Mondal PhD DABT is a highly experienced toxicologist currently serving as Senior Director of Toxicology at AbbVie since August 2024, focusing on neuroscience programs. Previously, Madhu held the position of Head of Toxicology at Cerevel Therapeutics, LLC, where responsibilities included setting nonclinical project toxicology strategies and managing IND/NDA enabling toxicology packages. Additional experience includes leading nonclinical safety strategies at FORMA Therapeutics and serving in various toxicology roles at AstraZeneca, Novartis Institutes for BioMedical Research, Pfizer, and Large Scale Biology Corp. Educational achievements encompass a Ph.D. in Molecular Pharmacology from Tata Institute of Fundamental Research, along with postdoctoral fellowships at Harvard Medical School and the University of Oxford.